Orbimed Advisors LLC Edgewise Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 15,021,721 shares of EWTX stock, worth $377 Million. This represents 10.86% of its overall portfolio holdings.
Number of Shares
15,021,721
Previous 15,021,721
-0.0%
Holding current value
$377 Million
Previous $401 Million
0.04%
% of portfolio
10.86%
Previous 9.45%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Ra Capital Management, L.P. Boston, MA8.91MShares$223 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$154 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$151 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$125 Million10.85% of portfolio
-
Janus Henderson Group PLC London, X04.98MShares$125 Million0.07% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.58B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...